# FDA 483 - Wuxi Biologics Co Ltd - June 04, 2024

Source: https://www.globalkeysolutions.net/records/483/wuxi-biologics-co-ltd/f42eaa83-6c51-4d59-9e00-368135ec25aa

> FDA 483 for Wuxi Biologics Co Ltd on June 04, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Wuxi Biologics Co Ltd
- Inspection Date: 2024-06-04
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [483 - 2019-04-16](https://www.globalkeysolutions.net/records/483/wuxi-biologics-co-ltd/1e3cf4c9-91d3-4f51-9777-fa2ca89cedb2)
- [EIR - 2019-04-08](https://www.globalkeysolutions.net/records/eir/wuxi-biologics-co-ltd/526d92cf-0cca-4b1c-870b-888c1217bf8f)
- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/wuxi-biologics-co-ltd/26a1ab27-8201-4905-bd86-a9acc1fc10cb)
- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/wuxi-biologics-co-ltd/f0964647-898f-41a5-87d5-745708bc6186)
- [483 - 2019-04-16](https://www.globalkeysolutions.net/records/483/wuxi-biologics-co-ltd/7acd63ae-9205-4cf2-a63d-66d26e115d67)

## Related Officers

- [Hamet Touré, PharmD MPH, Regulatory Officer](https://www.globalkeysolutions.net/people/hamet-toure-pharmd-mph-regulatory-officer/90e0a7c5-7fff-4dfe-a893-7d7cad038a15)
- [Jun Liu, Ph.D., Senior Biologist](https://www.globalkeysolutions.net/people/jun-liu-phd-senior-biologist/b602698c-6139-4860-928f-1c7706da4b54)

Company: https://www.globalkeysolutions.net/companies/wuxi-biologics-co-ltd/67a28116-624d-42f6-adae-18cf80094862

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd